Lixte Biotechnology Holdings, Inc. (LIXT) Stock Analysis
DELISTED 2026
What happened to Lixte Biotechnology Holdings, Inc. (LIXT) stock?
Lixte Biotechnology Holdings, Inc. (LIXT) no longer trades on public markets. It was delisted in July 2026. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- July 2026
- Last recorded price (historical):
- $7.21 (last quote on record before the July 2026 delisting; historical, not a current quote)
Market cap $89.1M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Lixte Biotechnology Holdings, Inc. (LIXT). Lixte Biotechnology Holdings, Inc. is a drug discovery company focused on developing novel compounds that target enzyme targets related to serious diseases.
Last analyzed: May 9, 2026Lixte Biotechnology Holdings, Inc. (LIXT) Healthcare & Pipeline Overview
More about this archive record
Can I still buy LIXT shares?
No. LIXT stopped trading on public markets in July 2026, so the shares are not available through a broker. Anything you see quoted for LIXT elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before LIXT stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Lixte Biotechnology Holdings, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.